Connect your AI

Corvel CRVL Proceeds from issuance of common stock relating to employee stock plans

Proceeds from issuance of common stock relating to employee stock plans at other companies

Elevance HealthELV

$19.75M-64.3%

DoximityDOCS

——

Other financials

Income statement

Revenue$248.5M+7.4%

Gross profit$63.0M+8.3%

Net income$31.0M+17.4%

EPS (diluted)$0.61+19.6%

Balance sheet

Cash & equivalents$233.1M+36.6%

Total debt$28.1M+0.1%

Total equity$394.2M+22.4%

Total assets$643.0M+17.8%

Cash flow

Operating cash flow$29.5M+28.6%

CapEx$9.2M+5.9%

Free cash flow$20.3M+42.3%

Valuation

Market cap$3.03B-51.4%

Enterprise value$2.82B-53.8%

P/E27.4×-38.0×

P/S3.2×-3.8×

Profitability

Gross margin24.3%+0.9pp

Net margin11.5%+0.9pp

FCF margin11.5%+1.3pp

Returns & leverage

Return on equity30.8%-2.6pp

Debt / equity0.1×0.0×

Current ratio2×+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.

The official record: Corvel’s 10-K, filed May 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvel's proceeds from issuance of common stock relating to employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Corvel's proceeds from issuance of common stock relating to employee stock plans?: Corvel (CRVL) reported proceeds from issuance of common stock relating to employee stock plans of $431K in Q1 2026.
How has Corvel's proceeds from issuance of common stock relating to employee stock plans changed year-over-year?: Corvel's proceeds from issuance of common stock relating to employee stock plans increased by 5.9% year-over-year, from $407K to $431K.